Korro Bio
KRRO
92 hedge funds and large institutions have $466M invested in Korro Bio in 2025 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 28 increasing their positions, 20 reducing their positions, and 5 closing their positions.
440% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 5
306% more capital invested
Capital invested by funds: $115M → $466M (+$351M)
40% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 20
31% more funds holding
Funds holding: 70 → 92 (+22)
7.58% more ownership
Funds ownership: 96.39% → 103.97% (+7.6%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$9.24M |
| 2 |
TLP
Tri Locum Partners
New York
|
+$4.4M |
| 3 |
JP Morgan Chase
New York
|
+$4.35M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$2.02M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$4.37M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$3.47M |
| 3 |
ABG
Ally Bridge Group
New York
|
-$1.93M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.68M |
| 5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$634K |
KRRO Hedge Fund Activity: Q3 2025 in Review
92 of the 7,642 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q3 2025, worth a combined $466M — up 306% from $115M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new KRRO positions and 5 closed out — a net gain of 22 holders — while 28 added to existing stakes and 20 trimmed.
The largest buyer was TCG Crossover Management, opening a new position worth an estimated $9.24M. The largest seller was Citadel Advisors, cutting an estimated $4.37M.
- 92 institutional investors held Korro Bio (KRRO) as of Q3 2025, up from 70 in Q2 2025.
- Funds reported $466M of Korro Bio stock for Q3 2025, up 306% quarter-over-quarter.
- 27 funds opened new Korro Bio positions in Q3 2025 and 5 closed out, a net change of +22 holders.
- The largest Korro Bio buyer in Q3 2025 was TCG Crossover Management, an estimated $9.24M added.
- The largest Korro Bio seller in Q3 2025 was Citadel Advisors, an estimated $4.37M sold.
Based on aggregated 13F filings for Q3 2025.